International Myeloma Society (IMS) | 3rd Annual Workshop on Genomics 2025 – Genomics and Translational Medicine in Myeloma

Short Description

Stay at the forefront of multiple myeloma research and precision oncology with the International Myeloma Society (IMS) 3rd Annual Workshop on Genomics 2025. This advanced scientific meeting explores the latest breakthroughs in myeloma genomics, translational medicine, molecular diagnostics, and targeted therapies, providing healthcare professionals with cutting-edge knowledge to improve diagnosis, risk stratification, and personalized treatment strategies.

Full Description

The International Myeloma Society (IMS) 3rd Annual Workshop on Genomics 2025: Genomics and Translational Medicine in Myeloma is a premier educational event dedicated to advancing the understanding of the genomic biology of multiple myeloma and related plasma cell disorders. Bringing together internationally recognized experts in hematology, oncology, molecular pathology, genomics, and translational research, this workshop focuses on transforming scientific discoveries into meaningful clinical applications.

Participants will gain comprehensive insights into the molecular mechanisms driving myeloma progression, including clonal evolution, genomic instability, tumor heterogeneity, immune escape, and interactions within the bone marrow microenvironment. The program also highlights the rapidly expanding role of advanced genomic technologies—including next-generation sequencing (NGS), single-cell sequencing, spatial transcriptomics, and liquid biopsy—in disease diagnosis, prognostication, minimal residual disease (MRD) assessment, and precision medicine.

Ideal for clinicians, researchers, and laboratory professionals, this workshop provides evidence-based updates and practical strategies for integrating genomic data into personalized patient care and future therapeutic development.

Learning Objectives

Upon completion of this educational activity, participants will be able to:

Myeloma Genomics

• Understand the genomic architecture of multiple myeloma.
• Interpret mutational signatures and genomic abnormalities.
• Evaluate clonal evolution from MGUS and Smoldering Multiple Myeloma to relapsed and refractory disease.
• Recognize mechanisms of disease progression and treatment resistance.

Advanced Genomic Technologies

• Evaluate the clinical applications of next-generation sequencing (NGS).
• Understand single-cell sequencing technologies.
• Apply spatial transcriptomics in translational research.
• Interpret genomic data for clinical decision-making.

Tumor Microenvironment & Immunology

• Understand the role of the bone marrow microenvironment.
• Evaluate immune evasion mechanisms in multiple myeloma.
• Assess biomarkers predicting immunotherapy response.
• Explore interactions between tumor cells and immune cells.

Precision Medicine

• Apply molecular profiling for risk stratification.
• Utilize liquid biopsy for minimal residual disease (MRD) monitoring.
• Integrate genomic biomarkers into personalized treatment selection.
• Explore emerging targeted therapies and precision oncology approaches.

What You’ll Learn

• Multiple myeloma genomics
• Clonal evolution
• Molecular pathogenesis
• Tumor heterogeneity
• Precision oncology
• Translational medicine
• Next-generation sequencing (NGS)
• Single-cell sequencing
• Spatial transcriptomics
• Liquid biopsy
• Minimal residual disease (MRD)
• Bone marrow microenvironment
• Immune escape mechanisms
• Molecular diagnostics
• Biomarker discovery
• Risk stratification
• Targeted therapies
• Clinical genomics
• Emerging therapeutic strategies
• Personalized cancer treatment

Who Should Enroll?

This workshop is ideal for:

• Hematologists
• Medical Oncologists
• Molecular Pathologists
• Geneticists
• Immunologists
• Hematopathologists
• Clinical Researchers
• Translational Scientists
• Laboratory Scientists
• Precision Medicine Specialists
• Medical Residents
• Hematology & Oncology Fellows
• Researchers studying plasma cell disorders
• Healthcare professionals involved in multiple myeloma management

Why Choose This Workshop?

• Organized by the International Myeloma Society (IMS)
• Advanced education focused on multiple myeloma genomics
• International faculty of leading researchers and clinicians
• Comprehensive coverage of precision medicine and translational research
• Evidence-based clinical updates
• Cutting-edge genomic technologies and molecular diagnostics
• Practical applications for clinical practice and research
• High-yield educational content for specialists and trainees
• Excellent resource for continuing medical education and professional development

Workshop Information

Topics:

• Session 1 – Current Definition and Management of Precursor Conditions
• Session 2 – Precursor Disease Genomics and Microenvironment
• Session 3 – The Future of Precursor Disease – Balancing Treatment and Innovation
• Session 4 – Deciphering Single Cells in MM
• Session 5 – Genomics in MM and Other Plasma Cell Dyscrasias
• Session 6 – Novel Targets in Plasma Cell Dyscrasias
• Session 7 – MM and Other Plasma Cell Disorders
• Session 8 – Proteomics and Methylation